CYTOMX - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
87421067
Word Mark
CYTOMX
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2021-03-29
Filing Date
2017-04-21
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2017-12-26
Attorney Name
Law Office Assigned Location Code
N60
Employee Name
HESIK, APRIL ANNE
Statements
Goods and Services
Biochemicals for scientific, laboratory, and research use, namely, proteolytically-activatable, protease-activatable, or proteolytically activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells and antigens; diagnostic kits for scientific, laboratory, and research use comprising proteolytically-activatable or protease-activatable, proteolytically-activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells, and antigens; immunoglobulin and antigen-binding fragments for drug conjugation and targeted cell binding for laboratory and research use; assays and reagents for use in scientific, laboratory and research purposes; biochemical test kits comprising assays and reagents for scientific, laboratory and research purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for scientific, laboratory and research use
Goods and Services
infections, inflammation; infections, inflammation; infections, inflammation; engineered cell therapies for medical purposes, namely, for use in treating cancer, infections, autoimmunity, and inflammation; infections, inflammation; assays and reagents for use in medical, medical diagnostic and therapeutic purposes for proteolytic activation and binding to tumor cells; biochemical test kits comprised of assays and reagents for medical, medical diagnostic and therapeutic purposes for proteolytic activation and binding to tumor cells; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery for medical, medical diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for use in identifying candidate patient populations for specific therapeutic treatments for medical purposes; therapeutic kits comprising proteolytically-activatable or protease-activatable, proteolytically-activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells, and antigens
Goods and Services
Scientific research and development in the field of therapeutic biochemicals, engineered cell therapies and immunotherapy, oncology and dysregulated proteolytic activity; medical and scientific research and development for agents, preparations, products and technology in the field of dysregulated proteolytic activities; providing medical and scientific research information in the fields of biochemicals, engineered cell therapies, immunotherapy, oncology and dysregulated proteolytic activity; scientific investigations for medical purposes; medical research; providing scientific and medical research information and analysis relating to biochemicals, engineered cell therapies and immunotherapy, proteolytic activation, antibody binding, therapeutic treatments, patient recovery, and the identification of candidate patients for specific therapeutic treatments; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; research, design and development of assays for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services; online computer services in the nature of providing a search engine for obtaining data, namely, searching, retrieving, and providing information on antibodies and research topics pertaining to antibodies on a global computer network
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2017-04-28
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-04-28
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2017-04-28
Primary Code
042
Correspondences
Name
Stephanie K. Wade
Address
Please log in with your Justia account to see this address.
Prior Registrations
| Relationship Type | Reel Number |
| Continuity Child | 87978592 |
Madrid International Filings
Entry Number
1
Reference Number
A0070817
Original Filing Date USPTO
2017-10-19
International Registration Number
1406697
International Registration Date
2017-10-19
International Status Code
480
International Renewal Date
2027-10-19
| Madrid History Events | ||
| Date | Code | Description |
| 2018-03-08 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
| 2018-03-09 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
| 2018-03-09 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
| 2019-02-19 | CBNAR | CEASING OF EFFECT REVIEWED - NO ACTION REQUIRED BY OFFICE |
| 2017-10-20 | ACERT | AUTOMATICALLY CERTIFIED |
| 2017-10-20 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
| 2017-10-20 | APPST | IR CERTIFIED AND SENT TO IB |
| 2018-06-14 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
| 2019-02-06 | CBPCP | PARTIAL CEASING OF EFFECT TO BE PROCESSED |
| 2021-11-18 | CBMPP | CEASING OF EFFECT PROCESSED |
| 2021-11-18 | CBPSP | PARTIAL CEASING OF EFFECT NOTICE SENT TO IB |
| 2017-11-20 | IRREG | IRREGULARITY NOTICE RECEIVED FROM IB |
| 2018-09-21 | DBCRP | DIVISIONAL OF BASE APP NOTICE CREATED, TO BE SENT TO IB |
| 2018-02-08 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
| 2018-09-21 | DBCSP | DIVISIONAL OF BASE APP NOTICE SENT TO IB |
| 2018-02-08 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
| 2021-12-25 | PCBNP | PARTIAL CEASING OF EFFECT PROCESSED BY IB |
| 2018-02-15 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
| 2018-02-27 | IRREG | IRREGULARITY NOTICE RECEIVED FROM IB |
| 2018-02-15 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
| 2021-10-20 | CBPCP | PARTIAL CEASING OF EFFECT TO BE PROCESSED |
| 2018-02-07 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
| 2018-11-16 | PDBNX | DIVISION OF BASE APPLICATION PROCESSED BY IB |
| 2018-02-14 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
Trademark Events
| Event Date | Event Description |
| 2017-04-25 | NEW APPLICATION ENTERED IN TRAM |
| 2017-04-28 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2017-07-17 | ASSIGNED TO EXAMINER |
| 2017-07-24 | PRIORITY ACTION WRITTEN |
| 2017-07-24 | PRIORITY ACTION E-MAILED |
| 2017-07-24 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| 2017-11-08 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2017-11-08 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2017-11-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2017-11-14 | EXAMINERS AMENDMENT -WRITTEN |
| 2017-11-14 | EXAMINERS AMENDMENT E-MAILED |
| 2017-11-14 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2017-11-14 | EXAMINER'S AMENDMENT ENTERED |
| 2017-11-14 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2017-12-06 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2017-12-26 | PUBLISHED FOR OPPOSITION |
| 2017-12-26 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2018-02-06 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 2018-02-16 | ASSIGNED TO PETITION STAFF |
| 2018-02-20 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2018-02-26 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| 2018-08-20 | TEAS EXTENSION RECEIVED |
| 2018-08-20 | TEAS REQUEST TO DIVIDE RECEIVED |
| 2018-09-17 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2018-08-20 | DIVISIONAL REQUEST RECEIVED |
| 2018-09-20 | DIVISIONAL PROCESSING COMPLETE |
| 2018-08-20 | EXTENSION 1 FILED |
| 2018-09-20 | EXTENSION 1 GRANTED |
| 2018-09-21 | CORRECTED NOA E-MAILED |
| 2018-09-21 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2019-02-15 | TEAS EXTENSION RECEIVED |
| 2019-02-15 | EXTENSION 2 FILED |
| 2019-02-15 | EXTENSION 2 GRANTED |
| 2019-02-19 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2019-08-19 | TEAS EXTENSION RECEIVED |
| 2019-08-19 | EXTENSION 3 FILED |
| 2019-08-19 | EXTENSION 3 GRANTED |
| 2019-08-22 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2019-10-16 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2019-10-16 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-01-21 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-01-21 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-01-30 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-01-30 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-02-05 | TEAS EXTENSION RECEIVED |
| 2020-02-05 | EXTENSION 4 FILED |
| 2020-02-05 | EXTENSION 4 GRANTED |
| 2020-02-07 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-07-29 | TEAS EXTENSION RECEIVED |
| 2020-08-03 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2020-08-10 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2020-07-29 | EXTENSION 5 FILED |
| 2020-08-11 | EXTENSION 5 GRANTED |
| 2020-08-12 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2021-03-29 | ABANDONMENT - NO USE STATEMENT FILED |
| 2021-03-29 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
